A PYMNTS Company

Pay-For-Delay: Who Does the Generic Industry Lobby Represent?

BY | May 11, 2020

The generic industry lobby, Association for Accessible Medicines (“AAM”), often represents the public interest. In the pharmaceutical industry, it challenges brand drug companies’ anticompetitive conduct. It fights for lower prices…

The generic industry lobby, Association for Accessible Medicines (“AAM”), often represents the public interest. In the pharmaceutical industry, it challenges brand drug companies’ anticompetitive conduct. It fights for lower prices for consumers. And it has built up goodwill for its work in these areas. But there is one glaring exception. Brand and generic companies often settle patent litigation. And sometimes they do so with the brand paying the generic to delay entry. To state the obvio

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.192.94.177

Please verify email or join us to access premium content!